Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001304857-05-000011
Filing Date
2005-09-08
Accepted
2005-09-08 16:34:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 13G SEPTEMBER 8, 2005 inkine13-g.txt SC 13G 8418
  Complete submission text file 0001304857-05-000011.txt   10567
Mailing Address 1787 SENTRY PARKWAY WEST BUILDING 18 SUITE 440 BLUE BELL PA 19422
Business Address 1787 SENTRY PARKWAY WEST BUILDING 18 SUITE 440 BLUE BELL PA 19422 2152836850
INKINE PHARMACEUTICAL CO INC (Subject) CIK: 0000929547 (see all company filings)

EIN.: 133754005 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-47845 | Film No.: 051075624
SIC: 2834 Pharmaceutical Preparations

Mailing Address P.O. BOX 32021 SMB, ANCHORAGE CENTRE 2ND FLOOR GRAND CAYMAN E9 BWI
Business Address P.O. BOX 32021 SMB, ANCHORAGE CENTRE 2ND FLOOR GRAND CAYMAN E9 BWI 416-408-0997
MMCAP International Inc. SPC (Filed by) CIK: 0001304857 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G